Novartis Escapes FCA Suit Over Xolair Marketing
A Massachusetts federal judge on Tuesday nixed a lawsuit accusing Novartis Pharmaceuticals Corp. and Genentech Inc. of off-label marketing and providing kickbacks to sell an asthma drug, saying fraud was "probable,"...To view the full article, register now.
Already a subscriber? Click here to view full article